Here is my story: - please read as it has changed a bit this year as cancer returned to our family.
As many of you know, I was diagnosed with Follicular Lymphoma early in 2004 (which looking back may have been Diffuse B Cell according to my Oncologist of 14 years). Likely related to 2-4-D (think Roundup) << And finally it's coming to light!!
I went through the CHOP-R regimen where like many cancer patients, I lost my hair and experienced other fun chemo effects. Still, I am one of the fortunate ones. The side effects I went through were absolutely worth it as the cancer was kicked to the curb and I have been in remission (possibly cured) with no treatment since that time which has allowed me to watch my beautiful family grow from then toddlers to high school. Incidentally, the -R (Rituximab) in my treatment was a newly developed drug at that time and I give it a lot of credit in my very positive response to the treatment.
Fred Hutch played a significant role in my diagnosis, and treatment where I received autologous stem cell collection at the Hutch. The care was tremendous! Fortunately, I'm still in remission.
Last September (2018), my family was hit by cancer, again. This time, my mother, Trudi Martin was struck down very suddently by metastasized ovarian cancer that had spread to many internal organs. She started feeling sick at the beginning of September. She was diagnosed a couple of weeks later and died just a few weeks after that. Incredibly sudden. Horrible disease. This year I ride for my mother, Trudi.
I'm thankful for each of you and the place you have in my life. I can't think of too many better causes. This will be I believe my fourth straight ride. I've been able thank to you all to raise over $3000 each year, nearly hitting $5000 last year. I'm again leading a small team.
It's time for us to put cancer in its place. Behind us. Ride with me, donate to my ride, and tell others about Obliteride. Fred Hutch is a world leading cancer research facility.
I'm asking you to join me in the fight against cancer.